Non-transferrin-bound iron reaches mitochondria by a chelator-inaccessible mechanism: Biological and clinical implications

American Journal of Physiology - Cell Physiology

Volumn 293, Issue 4, 2007, Pages

  Shvartsman, Maya ^a   Kikkeri, Raghavendra ^b   Shanzer, Abraham ^b   Cabantchik, Z Ioav ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Fluorescence; Oxidative stress; Transport

Indexed keywords

AMMONIUM SULFATE; CALCEIN; CHELATING AGENT; DEFEROXAMINE; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; FERRIC AMMONIUM CITRATE; FERRIC CITRATE; FERRIC HYDROXYQUINOLINE; FERROUS AMMONIUM SULFATE; IRON; QUINOLINOL DERIVATIVE; REACTIVE OXYGEN METABOLITE; RHODAMINE B; TRANSFERRIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CYTOSOL; DRUG STRUCTURE; FLUORESCENCE MICROSCOPY; FLUOROMETRY; IRON OVERLOAD; IRON TRANSPORT; MITOCHONDRION; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL;

ALDEHYDES; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CYTOSOL; DEFEROXAMINE; EGTAZIC ACID; FLUORESCEINS; FLUORESCENT DYES; FLUOROMETRY; HYDRAZONES; IRON; IRON CHELATING AGENTS; MICROSCOPY, FLUORESCENCE; MITOCHONDRIA; MODELS, BIOLOGICAL; MYOCYTES, CARDIAC; PROTEIN BINDING; RHODAMINES; SPECTROMETRY, FLUORESCENCE; TRANSFERRIN;

EID: 35048833703     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00054.2007     Document Type: Article

References (44)

1. Abramoff MD, Magelhaes PJ, Ram SJ. Image processing with ImageJ. Biophotonics Int 11: 36-42, 2004.
2. Andrews NC. Molecular control of iron metabolism. Best Pract Res Clin Haematol 18: 159-169, 2005.
3. Barasch J, Mori K. Iron thievery. Nature 432: 811-813, 2004.
4. Breuer W, Epzstejn S, Cabantchik ZI. Iron acquired from transferrin by K562 cells is delivered into a cytoplasmic pool of chelatable iron(II). J Biol Chem 270: 24209-24215, 1995.
5. Britigan BE, Rasmussen GT, Cox CD. Binding of iron and inhibition of iron-dependent oxidative cell injury by the "calcium chelator" 1,2-bis(2-aminophenoxy)ethane N,N,N′,N′-tetraacetic acid (BAPTA). Biochem Pharmacol 55: 287-295, 1998.
6. Cabantchik ZI, Breuer W, Zanninelli G, Cianculli P. LPI - labile plasma iron in iron overload. Best Pract Res Clin Haematol 18: 277-287, 2005.
7. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem 275: 25122-25129, 2000.
8. Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91: 9-18, 2002.
9. Ekkehard L, Veigel R, Ortner K, Nachtigal C, Steimann M. Preparation, properties, and reactions of metal-containing heterocycles. 101. Inclusion of copper(I) into a novel bipyridine containing tetraphosphadiplatinacyclophane. Eur J Inorg Chem 5: 959-969, 2000.
10. Esposito BP, Epsztejn S, Breuer W, Cabantchik ZI. A review of fluorescence methods for assessing labile iron in cells and biological fluids. Anal Biochem 304: 1-18, 2002.
11. Finney LA, O'Halloran TV. Transition metal speciation in the cell: insights from the chemistry of metal ion receptors. Science 300: 931-936, 2003.
12. Glickstein H, Ben-El R, Shvartsman M, Cabantchik ZI. Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells. Blood 106: 3242-3250, 2005.
13. Glickstein H, Ben-El R, Link G, Breuer W, Konijn AM, Hershko C, Nick H, Cabantchik ZI. Action of chelators in iron-loaded cardiac cells: accessibility to intracellular labile iron and functional consequences. Blood 108: 3195-3203, 2006.
14. Hentze MW, Muckenthaler MU, Andrews NC. Balancing acts: molecular control of mammalian iron metabolism. Cell 117: 285-297, 2004.
15. Jornot L, Petersen H, Junod AF. Hydrogen peroxide-induced DNA damage is independent of nuclear calcium but dependent on redox-active ions. Biochem J 335: 85-94, 1998.
16. Link G, Konijn AM, Hershko C. Cardioprotective effect of α-tocopherol, ascorbate, deferoxamine, and deferiprone: mitochondrial function in cultured, iron-loaded heart cells. J Lab Clin Med 133: 179-188, 1999.
17. Liu ZD, Hider RC. Design of clinically useful iron(III)-selective chelators. Med Res Rev 22: 26-64, 2002.
18. Luk E, Jensen LT, Culotta VC. The many highways for intracellular trafficking of metals. J Biol Inorg Chem 8: 803-809, 2003.
19. Ma Y, Yeh M, Yeh K, Glass J. Iron Imports. V. Transport of iron through the intestinal epithelium. Am J Physiol Gastrointest Liver Physiol 290: G417-G422, 2006.
20. Matarin MM, Singleton AB, Houlden H. PANK2 gene analysis confirms genetic heterogeneity in neurodegeneration with brain iron accumulation (NBIA), but mutations are rare in other types of adult neurodegenerative disease. Neurosci Lett 407: 162-165, 2006.
21. Meijler MM, Arad-Yellin R, Cabantchik ZI, Shanzer A. Synthesis and evaluation of iron chelators with masked hydrophilic moieties. J Am Chem Soc 124: 12666-12667, 2002.
22. Moriya M, Linder MC. Vesicular transport and apotransferrin in intestinal iron absorption, as shown in the Caco-2 cell model. Am J Physiol Gastrointest Liver Physiol 290: G301-G309, 2006.
23. Muhlenhoff U, Stadler JA, Richhardt N, Seubert A, Eickhorst T, Schweyen RJ, Lill R, Wiesenberger G. A specific role of the yeast mitochondrial carriers MRS3/4p in mitochondrial iron acquisition under iron-limiting conditions. J Biol Chem 278: 40612-40620, 2003.
24. Napier I, Ponka P, Richardson DR. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105: 1867-1874, 2005.
25. Nishikawa M, Nojima S, Akiyama T, Sankawa U, Inoue K. Interaction of digitonin and its analogs with membrane cholesterol. J Biochem (Tokyo) 96: 1231-1239, 1984.
26. Palmieri F. The mitochondrial transporter family (SLC25): physiological and pathological implications. Pflügers Arch 447: 689-709, 2004.
27. Pandolfo M. Iron metabolism and mitochondrial abnormalities in Friedreich ataxia. Blood Cells Mol Dis 29: 536-552, 2002.
28. Pantopoulos K. Iron metabolism and the IRE/IRP regulatory system: an update. Ann NY Acad Sci 1012: 1-13, 2004.
29. Petrat F, Weisheit D, Lensen M, De Groot H, Sustmann R, Rauen U. Selective determination of mitochondrial chelatable iron in viable cells with a new fluorescent sensor. Biochem J 362: 137-147, 2002.
30. Picard V, Renaudie F, Porcher C, Hentze MW, Grandchamp B, Beaumont C. Overexpression of the ferritin H subunit in cultured erythroid cells changes the intracellular iron distribution. Blood 87: 2057-2064, 1996.
31. Picard V, Epsztejn S, Santambrogio P, Cabantchik ZI, Beaumont C. Role of ferritin in the control of the labile iron pool in murine erythroleukemia cells. J Biol Chem 273: 15382-15386, 1998.
32. Pondarre C, Antiochos BB, Campagna DR, Clarke SL, Greer EL, Deck KM, McDonald A, Han AP, Medlock A, Kutok JL, Anderson SA, Eisenstein RS, Fleming MD. The mitochondrial ATP-binding cassette transporter Abcb7 is essential in mice and participates in cytosolic iron-sulfur cluster biogenesis. Hum Mol Genet 15: 953-964, 2006.
33. Ponka P. Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood 90: 1-25, 1997.
34. Ponka P, Grady RW, Wilczynska A, Schulman HM. The effect of various chelating agents on the mobilization of iron from reticulocytes in the presence and absence of pyridoxal isonicotinoyl hydrazone. Biochim Biophys Acta 802: 477-489, 1984.
35. Richardson DR, Mouralian C, Ponka P, Becker E. Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron. Biochim Biophys Acta 1536: 133-140, 2001.
36. Robb SJ, Robb-Gaspers LD, Scaduto RC, Thomas AP, Connor JR. Influence of calcium and iron on cell death and mitochondrial function in oxidatively stressed astrocytes. J Neurosci Res 55: 674-686, 1999.
37. Robinson AJ, Kunji ERS. Mitochondrial carriers in the cytoplasmic state have a common substrate binding site. Proc Natl Acad Sci USA 103: 2617-2622, 2006.
38. Santos NCF, Castilho RF, Meinicke AR, Hermes-Lima M. The iron chelator pyridoxal isonicotinoyl hydrazone inhibits mitochondrial lipid peroxidation induced by Fe(II)-citrate. Eur J Pharmacol 428: 37-44, 2001.
39. Schubert US, Eschbaumer C, Hochwimmer G. High yield synthesis of 5,5′-dimethyl-2,2′-bipyridine and 5,5″-dimethyl-2,2′: 6′,2″-terpyridine and some bisfunctionalization reactions using N-bromosuccinimide. Synthesis 5: 779-782, 1999.
40. Shaw GC, Cope JJ, Li L, Corson K, Hersey C, Ackermann GE, Gwynn B, Lambert AJ, Wingert RA, Traver D, Trede NS, Barut BA, Zhou Y, Minet E, Donovan A, Brownlie A, Balzan R, Weiss MJ, Peters LL, Kaplan J, Zon LI, Paw BH. Mitoferrin is essential for erythroid iron assimilation. Nature 440: 96-100, 2006.
41. Sheftel AD, Zhang AS, Brown C, Shirihai OS, Ponka P. Direct interorganellar transfer of iron from endosome to mitochondrion. Blood 110: 125-132, 2007.
42. Taketani S, Kakimoto K, Ueta H, Masaki R, Furukawa T. Involvement of ABC7 in the biosynthesis of heme in erythroid cells: interaction of ABC7 with ferrochelatase. Blood 101: 3274-3280, 2003.
43. Thomas F, Serratrice G, Béguin C, Saint Aman E, Pierre JL, Fontecave M, Laulhère JP. Calcein as a fluorescent probe for ferric iron. Application to iron nutrition in plant cells. J Biol Chem 274: 13375-13383, 1999.
44. Zhang AS, Sheftel AD, Ponka P. Intracellular kinetics of iron in reticulocytes: evidence for endosome involvement in iron targeting to mitochondria. Blood 105: 368-375, 2005.